A Psychiatrist's Diary

Recently published articles about A Psychiatrist's Diary

JCP
A Psychiatrist's Diary

November 15, 2007

JCP
A Psychiatrist's Diary

October 15, 2007

JCP
A Psychiatrist's Diary

August 15, 2007

JCP
A Psychiatrist's Diary

July 16, 2007

JCP
A Psychiatrist's Diary

June 15, 2007

JCP
A Psychiatrist's Diary

April 16, 2007

Recent PCC Articles on A Psychiatrist's Diary

Clinical Overview

July 17, 2026

An overview from Andrew Van Der Vaart, MD, on who responds to transcranial magnetic stimulation for depression, how it works, and how the standard, theta-burst, and SAINT protocols differ.
news

July 16, 2026

Two psychedelics show early GAD trial signals—DT120 and psilocybin—but no agent is approved for anxiety. Interpreting evidence by stage, not label, matters
JCP
Original Research ▶ Video

July 8, 2026

Findings suggest that active VNS reduces suicidal ideation (SI) and potentially induces SI remission among participants with chronic TRD and baseline SI.

Featured A Psychiatrist's Diary Research

news

July 7, 2026

DT120 (lysergide), a 5-HT2A agonist, eased GAD anxiety in trial. Beyond SSRIs/SNRIs, psychoplastogens offer new remission path.
news

July 7, 2026

GAD affects 10% of US adults yet remission stalls on SSRIs/SNRIs. New real-world data and psychedelic trials reveal the persistent treatment gap.
Where Autoantibodies Strike in Anti-NMDAR Encephalitis
news

January 26, 2026

A new study shows that antibodies in anti-NMDAR encephalitis target exposed hotspots on NMDA receptors, explaining synaptic disruption.
JCP
A Psychiatrist's Diary

March 15, 2007

JCP
A Psychiatrist's Diary

January 15, 2007

JCP
A Psychiatrist's Diary

December 15, 2006

JCP
A Psychiatrist's Diary

November 15, 2006

JCP
A Psychiatrist's Diary

October 16, 2006

JCP
A Psychiatrist's Diary

September 15, 2006

Consensus Report on XT Use in Practice

Read the full report

Subscribe to read
more articles

Subscribe